Ann: FDA Grants PharmAust Pre-IND Meeting, page-62

Those were the days , PAA charging ahead, WEHI results propelling the SP to 26c , best we wait for some MND results ,, the only promotion that counts now is what MT can put forward and what the BOD approve for expenditure..

Paid Content is the only way to gain Market Wide Exposure, we can't expect the same Market Reaction as the Biotechs that drive and Invest in their News..

Certainly Messaging has improved but it was from a very low base.... best of luck to all Holders ..

PAA is still on my list of Holdings but not near the top any longer ,,, Great Science , Skilled at generating Clinical Trials,,, but now its BUSINESS Time ,, with so many ASX Biotechs now wrapping up Phase II's and Phase III's under completion the Big Market focus is Commercialisation through Licensing and Outright Sale of Technologies....(one of my others just received a $10m down payment on a $240m licensing deal)
Another has Doubled 100% on FDA Application ,still waiting for it to be awarded..

Once the Catalysts of MND Phase I/II and the ODD application is completed there is a significant Phase II Trial ahead...

All of course ,,unless Big Pharma come running in on Blindingly Positive Phase I/II results and take the lot ... until PAA Capitalise on Scientific Progress to date PAA looks ripe for the Picking by Big Pharma.. Market Cap of $48m is a legacy from reputation,, soon that cloak should be thrown off BUT PAA has been in similar positions , Human Cancer, K9 Cancer, Covid SARs , HVTL-1 etc ...... Market is waiting and reserving judgment to see Commercial Reality and an Investment that benefits SH..... NZT